- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6813 - Hybridisation assays
Patent holdings for IPC class C12Q 1/6813
Total number of patents in this class: 999
10-year publication summary
65
|
46
|
29
|
92
|
87
|
109
|
156
|
100
|
85
|
25
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
22 |
Toray Industries, Inc. | 6652 |
20 |
President and Fellows of Harvard College | 5792 |
20 |
Gen-Probe Incorporated | 954 |
16 |
National Cancer Center | 365 |
16 |
Illumina, Inc. | 2771 |
12 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
11 |
Becton, Dickinson and Company | 6712 |
10 |
10X Genomics, Inc. | 921 |
8 |
Meso Scale Technologies, LLC | 347 |
8 |
Roche Sequencing Solutions, Inc. | 565 |
8 |
Centre National de La Recherche Scientifique | 9632 |
7 |
The General Hospital Corporation | 4517 |
7 |
Quantum-Si Incorporated | 395 |
7 |
University Health Network | 979 |
7 |
SomaLogic Operating Co., Inc. | 230 |
7 |
F. Hoffmann-La Roche AG | 7958 |
6 |
Monsanto Technology LLC | 7905 |
6 |
The Broad Institute, Inc. | 1584 |
6 |
Children's Medical Center Corporation | 1780 |
6 |
Other owners | 789 |